Jung Shin Byun, Ph.D., M.P.H.

Dr. Jung Shin Byun holds a Ph.D. in Biophysical Chemistry from the University of Maryland, College Park, and an M.P.H. from the Johns Hopkins University Bloomberg School of Public Health. Dr. Byun joined the DCTD at the NCI in 2023 as a Program Director. Before assuming in her current role, Dr. Byun conducted research at the NIH focusing on the development of biomarkers for tumor detection, diagnosis, and prognosis, alongside studies on pharmacological targeting for therapeutic discovery, genomics and tumor biology. She also led several cancer cohort projects and performed independent research in cancer epidemiology, focusing particularly on gene and environment interactions in diverse populations. 

With her extensive expertise spanning basic science, translational research, and population-based public health and epidemiology, Dr. Byun has contributed to advancing cancer research initiatives and training programs within the Division of Cancer Treatment and Diagnosis (DCTD).

Currently, she manages a diverse grant portfolio encompassing bioengineering, Innovative Molecular Analysis Technologies (IMAT), molecular and genomic profiling, and advanced sequencing technologies. Dr. Byun also fosters collaboration across multiple programs within DCTD and organizes the Division of Cancer Treatment and Diagnosis Technology Development Seminar Series, which showcases innovative advancements in cancer diagnosis and treatment technologies.

Selected Publications

• Sorg BS, Byun JS, Westbrook VA, Tricoli JV, Doroshow JH, Harris LN. NCI workshop on ctDNA in cancer treatment and clinical care. J Natl Cancer Inst. 2024;116(12):1890-1895.

• Tang W, Zhang F, Byun JS, et al. Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients. Cancer Res Commun. 2023;3(11):2244-2255.

• Singhal SK, Byun JS, Yan T, et al. Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race. JCI Insight. 2022;7(13):e157465. Published 2022 Jul 8.

• Singhal SK*, Byun JS*, Park S, et al. Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival. Commun Biol. 2021;4(1):150. Published 2021 Feb 1. (*Contributed equally)

• Byun JS*, Singhal SK*, Park S, et al. Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival. Clin Cancer Res. 2020;26(8):1905-1914. (*Contributed equally)

Additional Links to Scientific Publications

• ORCID

Education

• Ph.D., Biophysical Chemistry, University of Maryland College Park, MD, USA

• M.P.H., Bloomberg School of Public Health, Johns Hopkins University, MD, USA